Introducrion
The incubation of rheumatoid synovial cells (RSC) with the pro-inflammatory monokine, interleukin-1 (IL-1 ) results in a marked stimulation of glucose uptake and glycolysis [ I ] . The ability of IL-1 to affect the oxidation of glucose via the tricarboxylic acid cycle in connective tissue cells has been invcstigatcd in vitro using cultures of human dermal fibroblasts (HDF ). HDF were chosen in preference to RSC, since they exhibited a greater proliferative rate and a more pronounced glycolytic response to IL-1, as judged by the size of the increase in cellular fructose 2, 6)1', ] 121. After incubation with IL-la, the adherent cell monolayers in tissue culture flasks were placed in medium containing D-1 6-"C]glucose which only gives rise to I4CO2 by oxidation in the tricarboxylic acid cycle. The '"CO, generated was collected on to alkali-soaked filter papers as recently described 131. In addition to normal HDF, cells were also used from the skin o f patients with familial adenopolyposis (FAP) of the colon, a disease in which the dermal fibroblasts arc rcportcd t o exhibit altered growth characteristics in culture 14).
Murerids und methods
Recombinant human IL-I a with a specific activity of 1 x 10' units/mg was a gift from Dr D. Westmacott, Roche Products Ltd, Welwyn Garden City, U.K. HDF, obtained by outgrowth from small pieces of skin removed from the forearm of normal subjects and patients with FAP, were kindly provided by J. Wallis. The cells were cultured in 1 0 or 14 cm Petri dishes in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal calf serum (FCS), penicillin, streptomycin and fungizone in a watersaturated atmosphere o f 5% (v/v) CO, in air at 37°C. To study the effect of 1L-1 on glycolysis and glucose uptake, the cells were released by trypsin treatment and added to sixwell multiplatcs. As the cells approached confluency the medium was removed and fresh DMEM/FCS with or without 0.5 ng of IL-la/ml was added for 23 h. The culture medium was collected for glucose analysis and after several washings with balanced-salt solution, DMEM without FCS was added to the cells for a further 1 h incubation at 37°C. This medium was retained for lactate determination and the Abbreviations used: RSC. rheumatoid synovial cells; IL-I , interleukin-I ; HDF. human dermal fibrohlasts; FAP, familial adenopolyposis: DMEM. Dublecco's modified Eagle's medium: FCS. fetal calf serum; Fru ( 2, 6) P2, fructose 2.6-bisphosphate. cells were either solubilized with 50 mM-NaOH/ 1% (v/v) Triton X-100 for Fru ( 2, 6) P, determination or precipitated with 6% (w/v) perchloric acid for protein dctcrmination. Lactate production, glucose utilization, cellular Fru( 2,6)P2
and cell protein were measured as previously dcscribcd 1 I I [6-'4C] Glucose oxidation was measured in cells approaching confluency in 25 cm? tissue culture flasks. The cells were incubated for 18 h in DMEM/FCS with or without 0.5 ng of IL-la/ml. The medium was removed for glucose analysis and 1.4 ml of DMEM diluted 1 : l with Dulbecco's phosphate-buffered saline supplemented with 10% (v/v) FCS was added together with 1-2 pCi of D-[6-"C]glucosc (specific radioactivity 55.7 mCi/mmol). The flask was sealed and incubated for a further 5.5 h at 37°C. The l"COz generated within the flask was then quantitatively collected and measured as previously described [3] .
Resirlts and discussion
1L-1 a caused a significant stimulation o f glucose uptake, lactate production and cellular Fru( 2,6)P2 in both normal dermal fibroblasts and those derived from a patient with FAP (Table 1 ). The data indicate that 1L-1 is a potent stimulator of HDF glycolysis and that this increase is mediated in part by elevation of cellular Fru( 2,6)II2 with resulting activation of 6-phosphofructo-1 -kinase, as previously rcported for RSC. The relative importance of glycolysis for thcse cells in ritro is indicated by the high rate of lactate production, which at almost twice the rate of glucose uptake implies that very little glucose is metabolized by the tricarboxylic cycle. This agrees with previous observations o n a variety o f cultured cell types including chondrocytes as well as fibroblasts 151. With IL-1 a-treated fibroblasts, the glucose uptake appears insufficient to meet the observed lactate production; however, it must be remembered that the glucose uptake was measured over a 23 h period, during which time the rate is substantially increased by IL-1 a. whereas lactate production was assessed over 1 h, in cells already activated by the monokine.
Despite the low entry rate of glucose into the tricarboxylic acid cycle in the control dermal fibroblast cultures, the addition of relatively large amounts of tracer (1-2 pCi of [6-'JC]glucose) produced an average d.p.m. collected as lJCO, which was more than 10 times that from background radiation and non-metabolically generated IJCO2. This oxidation of glucose into IJCO, was found to be significantly reduced in both normal and FAP dermal fibroblasts treated with IL-1 a, when the data were analysed assuming a Poisson distribution for the d.p.m. Thus, despite stimulating glucose entry into the cells by approximately SO'%), IL-1 a actually reduced the amount of glucose being oxidized within the tricarboxylic acid cycle. The ability of IL-l to both stimulate glycolysis, but reduce glucose oxidation, provides further evidence for its involvement in endotoxic shock, a condition characterized by such a change in overall glucose 634th MEETING. BATH metabolism 161. A prominent feature of the action of IL-l o n a number of different cell types, including fibroblasts, is the stimulation o f prostaglandin production, particularly of the E series. Howevcr, inhibition of prostaglandin production by indomethacin ( 14 ,UM) did not affcct the monokine-induced changes in fibroblast glucose metabolism.
Corichtsiori
This study reports the effect of IL-1 a on glucose metabolism in both normal human dermal fibroblasts and those reported to exhibit altered growth characteristics in culture. IL-I increased glucose uptake and glycolysis which were associated with a decrease in glucose oxidation. This change in energy metabolism was not a consequence o f monokineinduced prostaglandin production.
The branched-chain amino acids (BCAA: leucine, isoleucinc, valine) are essential components of the mammalian diet. In the body they are catabolized by transamination (in skeletal muscle) and subsequent oxidation of the keto-acid (in muscle or liver); glutamate formed by transamination may be utilized by muscle to synthesize glutamine for export to other tissues (e.g. [ I , 21) . The mammalian liver appears to have little or no capacity to initiate catabolism of BCAA. Nevertheless, in the absorptive state the liver extracts a significant fraction of BCAA delivered by the portal circulation 1" . particularly after a fast 141, when rapid net synthesis of liver protein occurs (e.g. [ 5 ] for review). We decided to investigate the fate o f BCAA extracted by the liver during the fasted-fed transition, focusing on the contribution made by net liver synthesis of fixed and export (plasma) protein. We have also examined the possibility of BCAA release by the liver o f starved rats iri vivo. We have analysed liver BCAA Ahhreviations used: AA, amino acid; BCAA, branched-chain amino acid; HV. hepatic venous. flux in relation t o both hepatic portal and systemic arterial blood supply.
Female Wistar rats of -190 g initial body weight were used. Rats were fasted for 12 h (overnight: post-absorptive state) or 60 h (prolonged starvation); 60 h fasted rats were refed 1 g of protein (egg/bovine serum albumin mixture) or water (control) by gastric feeding tube. Liver flux of BCAA in anaesthetized rats (fentanyl-fluanisone, 0.13-4.0 mg/kg im.) was calculated from inflow-outflow blood concentration difference (portal and arterial routes) and liver blood flow. Blood samples [arterial, hepatic portal and hepatic venous (HV)] were obtained as described previously 141. Liver tissue was sampled by freeze clamping or thc whole liver was excised, weighed and homogenized (Polytron) for protein determination. Blood and liver concentrations of BCAA ([BCAA]) and total amino acids ( A A ) were measured by an automated amino acid analyser (Biotronik) using samples deprotcinized with 20% (w/v) sulphosalicylic acid containing norvaline as an internal standard. Hepatic portal blood flow was measured using either an ultrasonic flowmeter (Transonics Inc.) or by the 4hSc-labelled microsphere method (portal flow = X intestinal blood flows; 161); hepatic arterial blood flow was measured using microspheres. Liver BCAA flux was calculated as ([BCAA],, -[BCAA],,, ) x
